Ekso Bionics Holdings Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
11,887.40
33,769.00
19,590.00
23,470.00
29,122.00
26,992
Depreciation, Depletion & Amortization
468.90
745.00
933.00
1,855.00
1,732.00
1,515
Other Funds
947.80
-
-
-
-
2,782
Funds from Operations
10,037.10
15,237.00
18,947.00
22,847.00
27,649.00
22,695
Changes in Working Capital
973.50
230.00
678.00
2,150.00
3,577.00
530
Net Operating Cash Flow
9,063.60
15,007.00
18,269.00
24,997.00
31,226.00
22,165
Capital Expenditures
393.70
1,487.00
1,492.00
1,096.00
456.00
Sale of Fixed Assets & Businesses
14.50
-
-
-
-
Net Investing Cash Flow
379.20
1,487.00
1,492.00
1,096.00
456.00
Issuance/Reduction of Debt, Net
5,099.70
2,596.00
60.00
6,851.00
54.00
Net Financing Cash Flow
8,509.40
40,879.00
14,123.00
23,307.00
42,568.00
Net Change in Cash
933.40
24,385.00
5,638.00
2,706.00
10,967.00
Free Cash Flow
9,457.30
16,494.00
19,761.00
26,093.00
31,682.00
Change in Capital Stock
4,357.50
43,475.00
14,183.00
16,456.00
42,622.00
Exchange Rate Effect
-
-
-
80.00
81.00
About Ekso Bionics Holdings
View Profile
